Source: VERIS Research Information Service
If you would like a copy of the complete scientific papers described in these summaries, please call VERIS at 1-800-554-1708.
BACKGROUND: The herb feverfew (Tanacetum parthenium) has been used for centuries as a folk remedy for migraine headaches and fever. Some clinical studies do support its use in the prevention, though not treatment, of migraines. However, traditional medicine has resisted the use of feverfew and other herbal treatments because their mechanism(s) of action has not been clearly understood.
RESEARCH: In an experiment, researchers investigated the anti-inflammatory effects of parthenolide, the principal active chemical in feverfew. A documented anti-inflammatory effect would explain much of how feverfew works.
RESULTS: The researchers found that feverfew has clear anti-inflammatory properties. Parthenolide binds to and inhibits the activity of "IKK-beta," which blocks the activity of another protein, "nuclear factor kappa B (NFkB)." This is significant because NFkB activates many genes involved in producing inflammation.
IMPLICATIONS: This study is important because it explains, at a molecular level, how the active component in feverfew stops inflammation. Such research provides an explanation for the benefits of feverfew in preventing migraines and reducing fever.
Kwok BHB, Koh B, Ndubuisi MI, et al, "The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkB kinase," Chemistry & Biology, 2001;8:759-766.
For the original abstract, visit: http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11514225&dopt=Abstract
The worldwide VERIS Research Information Service disseminates nutritional information, with emphasis on the health benefits derived from antioxidants. Cognis Nutrition and Health, a global leader in the production and marketing of natural-source antioxidants and botanical ingredients, provides a grant to VERIS in support of its mission to communicate scientific news and research findings. VERIS, a distinct corporate entity, began in 1985 and serves as a preeminent resource for scientific information. Visit www.cognis.com for more research news on antioxidants.